AYTU (ATYU) ‘Team’ Letter on Innovus (INNV) Acquisition.
Aytu Team:
I’m pleased to share with you some exciting, transformational news about Aytu BioScience that we announced publicly...
Booster Raises $56 million to Deliver Fuel Directly to Cars.
Booster, a San Mateo, California-based startup offering same-day fuel delivery service in the U.S., today announced that it’s raised $56 million in...
Innovus (INNV) Gains 75% in Past Week.
After Rough Sledding Post Reverse Split, Client Innovus Receives Buyout Offer From Nasdaq Listed Ayto Biosciences (AYTU).
Click...
Innovus Pharma Reports 2Q 2019 of $6.8 million, a 27.7% Increase from Prior Quarter.
Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) (OTCQB: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter...
My Size (MYSZ) Provides Business Update and Reports Results for the Second Quarter of...
Reports successful deployment of MySizeID with leading global retailers and apparel companies
AIRPORT CITY, Israel, Aug. 9, 2019 /PRNewswire/...
MySize (MYSZ) in Jerusalem Post.
Israeli Start-Up MySize Eases Retail's Online Returns Problems.
While the company launched its SizeUp application in late 2015,...
Latest article
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
